chevron_leftBack
As of 25 June 2026, Y-Biologics, Inc. has a market cap of $226.59M USD, ranking #20273 globally and #731 in South Korea.
It ranks #1814 in the Healthcare sector, and #352 in the Biotechnology industry.
Key Stats
Market Cap
$226.59MUSD
347.58B KRW
Enterprise Value
$206.02MUSD
318.06B KRW
Revenue (TTM)
$1.9MUSD
2.91B KRW
EBITDA (TTM)
-$4.75MUSD
-7.34B KRW
Net Income (TTM)
-$27.4MUSD
-42.02B KRW
EBITDA Margin
-252%
PS Ratio
119.3
PB Ratio
13.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Young Woo Park
open_in_new
Founded
2007
Website
ybiologics.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.1% | -1.3% | -34% | -9.7% | 17% | 214% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
338840
(주)와이바이오로직스
ISIN: KR7338840002
Shares Out.:
Shares Outstanding:
15.367M1
Shares Float:
10.323M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
22,900 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Y-Biologics, Inc.
Y-Biologics, Inc., an antibody therapeutics development company, engages in the research and development of immuno-oncology drugs and antibody drugs. The company develops YBL-006, a PD-1 immune-oncology agent that is phase 1 clinical stage for the treatment of solid tumor. It also develops immunoregulatory monoclonal antibodies, such as YBL-011 and AR062 for the treatment of solid cancers; AR166, AR169, and AR170 for solid cancers; and AR153, a pH-dependent antibody for the treatment of solid cancer. Y-Biologics, Inc. was incorporated in 2007 and is headquartered in Daejeon, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 207940
|
$44.45B
20K%
68.19T KRW
|
35.5
|
|
KRX: 068270
|
$27.87B
12K%
42.76T KRW
|
43.8
|
|
KRX: 196170
|
$13.26B
6K%
20.33T KRW
|
146.6
|
|
KRX: 028300
|
$5.46B
2K%
8.37T KRW
|
-
|
|
KRX: 087010
|
$3.96B
2K%
6.07T KRW
|
-
|
|
KRX: 302440
|
$2.23B
885%
3.42T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
80K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
70K%
|
19.0
|
|
EBR: ARGX
|
$47.1B
21K%
41.39B EUR
|
39.9
|
|
ASX: CSL
|
$41.65B
18K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.62B
18K%
33.71B CHF
|
37.2
|
|
NASDAQ: NTRA
|
$27.6B
12K%
|
-
|
chevron_leftBack